Nimbolide-based nanomedicine inhibits breast cancer stem-like cells by epigenetic reprogramming of DNMTs-SFRP1-Wnt/β-catenin signaling axis

Authors: Priyanka Mohapatra, Swati Madhulika, Somalisa Behera, Priya Singh, Pratikshya Sa, Punit Prasad, Rajeeb Kumar Swain, Sanjeeb Kumar Sahoo

Source: Molecular Therapy: Nucleic Acids, Vol 34, Iss , Pp 102031- (2023)

Subject Terms: MT: Delivery Strategies, triple-negative breast cancer, cancer stem cells, nanomedicine, nimbolide, epigenetics, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2162253123002445; https://doaj.org/toc/2162-2531

Access URL: https://doaj.org/article/acef2ec801374382be2cdcffd1d856b6